1. Ananthasubramaniam K, Beattie JN, Rosman HS, Jayam V, Borzak S. How safely and for how long can warfarin therapy be withheldin prosthetic heart valve patients hospitalized with a major hemorrhage? Chest. 2001;119(2):478–84.
2. Kawamata T, Takeshita M, Kubo O, Izawa M, Kagawa M, Takakura K. Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol. 1995;44(5):438–42.
3. Parolari A, Colli S, Mussoni L, Eligini S, Naliato M, Wang X, et al. Coagulation and fibrinolytic markers in a two-month followup of coronary bypass surgery. J Thorac Cardiovasc Surg. 2003;125(2):336–43.
4. Parolari A, Mussoni L, Frigerio M, Naliato M, Alamanni F, Galanti A, et al. Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery. J Thorac Cardiovasc Surg. 2005;130(2):303–8.
5. Devlin RJ, Henry JA. Clinical review: Major consequences of illicit drug consumption. Crit Care. 2008;12(1):202.
6. Montorsi P, Cavoretto D, Parolari A, Muratori M, Alimento M, Pepi M. Diagnosing prosthetic mitral valve thrombosis and the effect of the type of prosthesis. Am J Cardiol. 2002;90(1):73–6.